File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart

TitleModulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart
Authors
Issue Date2014
Citation
Journal of Physiology, 2014, v. 592, n. 12, p. 2535-2548 How to Cite?
AbstractElevations of cardiomyocyte apoptosis and fibrotic deposition are major characteristics of the ageing heart. Resveratrol, a polyphenol in grapes and red wine, is known to improve insulin resistance and increase mitochondrial biogenesis through the SIRT1-PGC-1α signalling axis. Recent studies attempted to relate SIRT1 activation by resveratrol to the regulation of apoptosis in various disease models of cardiac muscle. In the present study, we tested the hypothesis that long-term (8-month) treatment of resveratrol would activate SIRT1 and improve the cardiac function of senescent mice through suppression of Foxo1-associated pro-apoptotic signalling. Our echocardiographic measurements indicated that the cardiac systolic function measured as fractional shortening and ejection fraction was significantly reduced in aged mice when compared with the young mice. These reductions, however, were not observed in resveratrol-treated hearts. Ageing significantly reduced the deacetylase activity, but not the protein abundance of SIRT1 in the heart. This reduction was accompanied by increased acetylation of the Foxo1 transcription factor and transactivation of its target, pro-apoptotic Bim. Subsequent analyses indicated that pro-apoptotic signalling measured as p53, Bax and apoptotic DNA fragmentation was u p-regulated in the heart of aged mice. In contrast, resveratrol restored SIRT1 activity and suppressed elevations of Foxo1 acetylation, Bim and pro-apoptotic signalling in the aged heart. In parallel, resveratrol also attenuated the ageing-induced elevations of fibrotic collagen deposition and markers of oxidative damage including 4HNE and nitrotyrosine. In conclusion, these novel data demonstrate that resveratrol mitigates pro-apoptotic signalling in senescent heart through a deacetylation mechanism of SIRT1 that represses the Foxo1-Bim-associated pro-apoptotic signalling axis. © 2014 The Physiological Society.
Persistent Identifierhttp://hdl.handle.net/10722/244169
ISSN
2023 Impact Factor: 4.7
2023 SCImago Journal Rankings: 1.708
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSin, Thomas K.-
dc.contributor.authorYu, Angus P.-
dc.contributor.authorYung, Benjamin Y.-
dc.contributor.authorYip, Shea Ping-
dc.contributor.authorChan, Lawrence W.-
dc.contributor.authorWong, Cesar S.-
dc.contributor.authorYing, Michael-
dc.contributor.authorRudd, John A.-
dc.contributor.authorSiu, Parco M.-
dc.date.accessioned2017-08-31T08:56:14Z-
dc.date.available2017-08-31T08:56:14Z-
dc.date.issued2014-
dc.identifier.citationJournal of Physiology, 2014, v. 592, n. 12, p. 2535-2548-
dc.identifier.issn0022-3751-
dc.identifier.urihttp://hdl.handle.net/10722/244169-
dc.description.abstractElevations of cardiomyocyte apoptosis and fibrotic deposition are major characteristics of the ageing heart. Resveratrol, a polyphenol in grapes and red wine, is known to improve insulin resistance and increase mitochondrial biogenesis through the SIRT1-PGC-1α signalling axis. Recent studies attempted to relate SIRT1 activation by resveratrol to the regulation of apoptosis in various disease models of cardiac muscle. In the present study, we tested the hypothesis that long-term (8-month) treatment of resveratrol would activate SIRT1 and improve the cardiac function of senescent mice through suppression of Foxo1-associated pro-apoptotic signalling. Our echocardiographic measurements indicated that the cardiac systolic function measured as fractional shortening and ejection fraction was significantly reduced in aged mice when compared with the young mice. These reductions, however, were not observed in resveratrol-treated hearts. Ageing significantly reduced the deacetylase activity, but not the protein abundance of SIRT1 in the heart. This reduction was accompanied by increased acetylation of the Foxo1 transcription factor and transactivation of its target, pro-apoptotic Bim. Subsequent analyses indicated that pro-apoptotic signalling measured as p53, Bax and apoptotic DNA fragmentation was u p-regulated in the heart of aged mice. In contrast, resveratrol restored SIRT1 activity and suppressed elevations of Foxo1 acetylation, Bim and pro-apoptotic signalling in the aged heart. In parallel, resveratrol also attenuated the ageing-induced elevations of fibrotic collagen deposition and markers of oxidative damage including 4HNE and nitrotyrosine. In conclusion, these novel data demonstrate that resveratrol mitigates pro-apoptotic signalling in senescent heart through a deacetylation mechanism of SIRT1 that represses the Foxo1-Bim-associated pro-apoptotic signalling axis. © 2014 The Physiological Society.-
dc.languageeng-
dc.relation.ispartofJournal of Physiology-
dc.titleModulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1113/jphysiol.2014.271387-
dc.identifier.pmid24639483-
dc.identifier.scopuseid_2-s2.0-84902330009-
dc.identifier.volume592-
dc.identifier.issue12-
dc.identifier.spage2535-
dc.identifier.epage2548-
dc.identifier.eissn1469-7793-
dc.identifier.isiWOS:000337622600011-
dc.identifier.issnl0022-3751-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats